Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
24 participants
INTERVENTIONAL
2023-09-01
2024-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Employing a unilateral training design, participant's will have their legs randomized to one of four groups: non-exercise control (CON), exercise control (EX), Follicular based training (FOL), Luteal based training (LUT)
Researchers will compare these conditions to see if there are greater benefits to prioritizing resistance training around phases of the menstrual cycle,
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Different Menstrual Cycle in Eating Behavior Following Resistance Exercise
NCT06208475
Fatmax Exercise in Menstrual Phases: Effects on Fat Metabolism & Body Composition in NWO Women
NCT06961734
Effects of Resistance Training in Body Composition and Body Image Perception of Women Throughout the Menstrual Cycle
NCT04038463
Effects of Resistance Training on Substrate Metabolism During the Menstrual Cycle
NCT04024826
The Impact of the Menstrual Cycle on Physical Exercise and Performance
NCT05697263
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Non-Exercise Control (CON)
This condition will serve as a non-exercise control and will not be performing resistance exercise training (RET)
Non-Exercise Control Leg
One leg will serve as a non-exercise control
Follicular Based Training (FOL)
This condition will have high volume of RET (20 weekly sets) during the follicular phase and low volume during the luteal phase of the participant's menstrual cycle.
Unilateral Resistance Exercise Leg
One will perform unilateral resistance exercise
Luteal Based Training (LUT)
This condition will have high volume of RET (20 weekly sets) during the luteal phase and low volume during the follicular phase of the participant's menstrual cycle.
Unilateral Resistance Exercise Leg
One will perform unilateral resistance exercise
Exercise Control (EX)
This condition will have consistent training volume (12 weekly sets) throughout the duration of the study, regardless of what phase of the menstrual cycle the participant is in.
Unilateral Resistance Exercise Leg
One will perform unilateral resistance exercise
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Unilateral Resistance Exercise Leg
One will perform unilateral resistance exercise
Non-Exercise Control Leg
One leg will serve as a non-exercise control
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Have a body mass index (BMI) between 18-35 kg·m2 (inclusive)
* Be in general good health as assessed by a general health questionnaire
* Non-smoking
* Regular menstrual cycle (21-35 days, inclusive)
* Not using hormonal contraceptives
* Willing and able to provide informed consent
Exclusion Criteria
* Ineligible to participate in physical activity based on get active questionnaire (GAQ)
* Any concurrent medical, orthopedic, or psychiatric condition that, in the opinion of the Investigator, would compromise his/her ability to comply with the study requirements.
* Current illnesses which could interfere with the study (e.g. prolonged severe diarrhea, regurgitation, difficulty swallowing)
* Use of hormonal contraceptives
* Currently pregnant
* Training more than 3x/week for the past 6 months.
* Have any electronic medical or metal implants
* A history of neuromuscular disorders or muscle/bone wasting diseases
* The use of any medications known to affect protein metabolism (glucocorticoids, non-steroidal anti-inflammatory medication, or prescription strength acne medication, etc.)
* A (family) history of thrombosis
* The use of anticoagulant medications
* Excessive alcohol consumption (\>21 units/wk)
* History of bleeding diathesis, platelet or coagulation disorders, or antiplatelet/anticoagulation therapy
18 Years
30 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
McMaster University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Stuart Phillips
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Exercise Metabolism Research Laboratory, McMaster Univeristy
Hamilton, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
16355
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.